Revenio Group OyjREVXF 82 Days Inventory is 118.14 as of Mar. 2026, which is 20% above its 10-year median of 98.72. GuruFocus rates REVXF with a GF Score™ of 82/100 and a GF Value™ of $40.69 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Revenio Group Oyj ranks better than 75.95% on this metric.
The historical rank and industry rank for Revenio Group Oyj's Days Inventory or its related term are showing as below:
REVXF'
s Days Inventory Range Over the Past 10 Years
Min: 60.65 Med: 98.72 Max: 122.81
Current: 112.63
During the past 13 years, Revenio Group Oyj's highest Days Inventory was 122.81. The lowest was 60.65. And the median was 98.72.
REVXF's Days Inventory is ranked better than 75.95% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs REVXF: 112.63
Revenio Group Oyj's Days Inventory
declined
from Mar. 2025 (124.56) to Mar. 2026 (118.14).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Revenio Group Oyj's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Revenio Group Oyj's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.41.
Revenio Group Oyj (OTCPK:REVXF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Revenio Group Oyj's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Revenio Group Oyj's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Revenio Group Oyj Days Inventory Related Terms
Revenio Group Oyj Days Inventory Historical Data
* Premium members only.
The historical data trend for Revenio Group Oyj's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Revenio Group Oyj's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Days Inventory distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenio Group Oyj (REVXF) has a Days Inventory of 118.14 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Revenio Group Oyj and its competitors. This is 20% above median its historical median of 98.72. Over the past decade, Revenio Group Oyj's Days Inventory has ranged from 60.65 to 122.81. According to the industry distribution chart, Revenio Group Oyj ranks #189 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 24%.
Is Revenio Group Oyj's Days Inventory too high?
Revenio Group Oyj's current Days Inventory of 118.14 is 20% above median its 10-year median of 98.72. Over the past 10 years, this metric has ranged from a low of 60.65 to a high of 122.81. The Medical Devices & Instruments industry median Days Inventory is 179.60. Revenio Group Oyj's value of 118.14 is 34.2% below this industry median. Based on the distribution chart, Revenio Group Oyj ranks #189 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Revenio Group Oyj has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #189 out of 786 companies for Days Inventory. This places Revenio Group Oyj in the top 24% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Revenio Group Oyj's value of 118.14 is 34.2% below this benchmark. Historically, Revenio Group Oyj's own Days Inventory has ranged from 60.65 to 122.81 over the past decade. While the company's 10-year median is 98.72 vs. the industry median of 179.60, Revenio Group Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revenio Group Oyj's current Days Inventory of 118.14 is 34.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current Days Inventory is 118.14, which is 20% above median its own 10-year median of 98.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (REVXF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.69, compared to a current price of $16.41 — trading 59.7% below its estimated fair value. The current Days Inventory is 118.14, which is 20% above median its 10-year median of 98.72 and 34.2% below the Medical Devices & Instruments industry median of 179.60. Revenio Group Oyj's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Revenio Group Oyj (REVXF), the current Days Inventory is 118.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revenio Group Oyj (REVXF) Overvalued in 2026?
Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued.
The current stock price of $16.41 is trading 59.7% below its estimated GF Value™ of $40.69.
GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.
Key valuation signals for REVXF:
Days Inventory: 118.14 (20% above median its 10-year median of 98.72)
GF Value™: $40.69 vs. price of $16.41 (59.7% below fair value)
Industry Position: 34.2% below the Medical Devices & Instruments median (#189 of 786)
No single metric tells the full story. See the REVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
82GF Score
Get the complete analysis for REVXF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REVXF has been successfully added to your 
